Central pulmonary artery thromboembolism is a life threatening but treatable condition. The presentation can be acute, subacute, or chronic. The decrease in the cross sectional lumen in the pulmonary artery leads to an abrupt rise in the pulmonary arterial pressure,' then right heart pressure overload and a drop in cardiac output. If the condition deteriorates, the patient can go into cardiogenic shock. If the patient survives the acute phase, the thrombus can either fragment and resolve through the endogenous fibrinolytic system, or it can be endothelialised in the central pulmonary artery. Chronic pulmonary hypertension and right heart failure can be the end result.2 Therefore, prompt diagnosis and appropriate treatment are important in the acute phase and may influence long-term prognosis.
A number of investigations are currently available in the diagnosis of thromboemboli in the central pulmonary artery. Pulmonary angiography and nuclear ventilation-perfusion lung scan have been the most usual modes of imaging used. 3 Echocardiography has recently been used in the diagnosis of pulmonary embolism. Direct visualisation of central pulmonary artery emboli with transthoracic echocardiography (TTE) has only been reported for a few cases.45 This is because the central pulmonary artery and its main branches cannot be imaged clearly from the transthoracic approach. Transoesophageal echocardiography (TOE), however, offers the unique opportunity to image dearly the main pulmonary artery, its bifurcation, and a long section of the right main pulmonary artery. There have been several case reports on the use of transoesophageal echocardiography in the detection of central pulmonary artery emboli.6 7 We present five patients to show the use of TOE in direct visualisation of central pulmonary artery thromboemboli. We also studied the morphological features of the thromboemboli on echocardiography in an attempt to differentiate acute from chronic thromboemboli. The information obtained was taken into account to decide on treatment.
Case reports CASE 1
A 68 year old man with documented rectal adenocarcinoma and pelvic metastasis was admitted with a sudden onset of severe dyspnoea. Physical examination showed respiratory distress and raised jugular venous pressure, but no focal signs in the chest. There was no clinical evidence of deep venous thrombosis. A chest x ray film was normal.
Transthoracic echocardiography showed mild right ventricular dilatation. No abnormalities were detected in the pulmonary artery. When TOE was performed a long, thin, mobile thromboembolus in the right pulmonary artery was found, the appearance of which was consistent with a cast from a deep calf vein (fig 1 (A) ). A separate thromboembolus was seen in the right atrium (fig 1(B) ). Nuclear ventilation perfusion lung scans showed several mismatched defects consistent with pulmonary embolism.
Thrombus morphology on echocardiography suggested an acute thromboembolic event. The echocardiography showed a large thrombus extending from the bifurcation of the pulmonary artery into the right pulmonary artery as far as could be seen (fig 3) . It completely occluded the dilated right pulmonary artery. Colour flow Doppler showed evidence of canalisation within the thrombus suggesting that it was old. Venography showed occlusion of the right external iliac vein. Because anticoagulation treatment was contraindicated and the patient was judged to be unfit for surgical pulmonary thromboendarterectomy, he was treated with implantation of an inferior vena caval filter. Figure 3 Type B thromboemibolus occluding the right pulmlonary artery near the bifurcation of the main pulmonary arterv. SVC, superior vena cava; ASC AO, ascending aorta; MPA, mtain pulmlonary artery. CASE 5 A 57 year old woman presented with a sudden onset of left hemiparesis and hemianaesthesia. She had no respiratory symptoms. Electrocardiography was normal. Computed tomography showed a cerebral infarct in the right lentiform nucleus extending into the adjacent posterior limb of the internal capsule and corona radiata.
Transoesophageal echocardiography was performed to exclude a cardiac source of cerebral embolism. It unexpectedly showed a mobile laminated thrombus in the pulmonary artery starting at the bifurcation, extending 6-7 cm into the right pulmonary artery. The pulmonary artery pressure was high. A patent foramen ovale with right to left shunting was also found. Nuclear ventilation-perfusion lung scans showed multiple mismatched defects consistent with pulmonary embolism.
Thrombus morphology on echocardiography implied recent embolisation. The discovery of the right to left shunt on echocardiography strongly suggested the possibility of paradoxical embolism as the cause of her cerebral event. She was therefore treated with implantation of an inferior vena caval filter, then long term anticoagulation. Transoesophageal echocardiography has clear superiority over IT-E in patients with suspected central pulmonary artery thromboembolism. Transthoracic echocardiography provides mainly indirect evidence such as pulmonary hypertension and signs of right ventricular pressure overload. Thromboemboli in transit in the right heart can sometimes be detected by TITE.' Direct visualisation of central pulmonary artery thromboemboli is, however, a rare phenomenon.
The use of TOE in the diagnosis of central pulmonary artery thromboemboli has limitations. Only the extrapulmonary portion of the pulmonary arteries can be seen. Views of the left pulmonary artery in particular, are often limited to the first 2-3 cm. Therefore, absence of emboli on TOE does not necessarily exclude the diagnosis. If, however, no emboli are seen in the central portion of the pulmonary artery the patient is usually not critically compromised, so there is time for the diagnosis to be made by other modes of imaging.
The cases presented show the importance of differentiating various morphological types of central pulmonary artery thromboemboli as detected by echocardiography. Wittlich et aP described two types. Type A thrombi are long, thin, mobile structures. They move independently of the pulmonary artery as can be shown by M mode imaging. They represent emboli that originate from a deep venous thrombosis. As shown in cases 1 and 2, their presence seems to imply recent, acute embolic events. Aggressive treatment is often necessary. By contrast type B thrombi are immobile structures, often firmly adherent to the arterial wall. They represent organised embolic material that has been in the pulmonary artery for some time. They might even have originally developed in the pulmonary artery as a result of chronic pulmonary hypertension. As shown in case 4, partial recanalisation of the embolus can occur with blood flowing through these channels as detected by colour flow Doppler. This feature can be used to differentiate between a chronic thromboembolus and a very large acute embolus occluding the pulmonary artery. Therefore, thrombus morphology on echocardiography can be used to assess the time course of the embolic event and has important clinical implications in the decision about treatment.
The most appropriate treatment for massive pulmonary embolism caused by type A embolus remains unclear from the reported evidence. Thrombolytic treatment is supported by some reports. Vestraete et al reported a 6% mortality in patients with acute massive pulmonary embolism treated with recombinant tissue type plasminogen activator."I The time, however, to thrombolytic treatment was from 27 to 31 hours. Knowing that the mortality from massive pulmonary embolism reported by Mattox et al was 50% within 30 minutes, 70% within one hour, and 85% within six hours,'2 such a delay in treatment may have selected the subgroup of patients most likely to survive regardless of the form of treatment given.
In patients with massive pulmonary embolism and severe haemodynamic compromise who are too ill to be given thrombolytic treatment, or when thrombolysis is either contraindicated or too slow in producing benefit, surgical pulmonary embolectomy remains an effective alternative option, especially in patients with no coexisting medical conditions that raise the surgical risk. The surgical mortality has been reported as ranging from 24% to 64%.12 13 With advances in cardiopulmonary support and techniques in extracorporeal circulation, and the improvement in the speed of reaching a definitive diagnosis before the patient's condition deteriorates, the surgical mortality is likely to approach the 24% figure in the future.
Patients with chronic pulmonary hypertension due to unresolved pulmonary embolism of type B morphology are usually refractory to anticoagulants and thrombolytic treatment. Type B thrombi can sometimes be managed with pulmonary thromboendarterectomy. Moser et al reported 42 cases with a surgical mortality of 16-6%. Surgical success leads to a dramatic reduction of symptoms, with sustained reduction in pulmonary hypertension, reduction in the size of the pulmonary artery, right ventricle, right atrium, and inferior vena cava, with a normalisation of the interventricular septal position.
In conclusion, TOE is an alternative diagnostic tool in the detection of central pulmonary artery thromboemboli in patients with suspected severe pulmonary embolism. It has some distinct advantages over other modes of investigation. It is ideal clinically where a rapid diagnosis is vital in a critically ill patient who is unfit to be transferred elsewhere to undergo invasive angiography or lung scans. It offers vital information on ventricular function, the degree of pulmonary hypertension, and the presence of any relevant structural cardiac abnormalities. The 
